Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

907 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : International Paper Company, Q1 2024 Earnings Call, Apr 25, 2024
Transcript : Anand Rathi Wealth Limited, Q4 2024 Earnings Call, Apr 15, 2024
Transcript : Domino's Pizza Enterprises Limited - Analyst/Investor Day
Transcript : Koninklijke Ahold Delhaize N.V. - Shareholder/Analyst Call
Transcript : Agricultural Bank of China Limited, 2023 Earnings Call, Mar 28, 2024
Transcript : Randstad N.V. - Shareholder/Analyst Call
Transcript : Lincoln Educational Services Corporation - Analyst/Investor Day
Transcript : Mendus AB - Special Call
Transcript : Genuine Parts Company Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 09:15 AM
Transcript : UCB SA, 2023 Earnings Call, Feb 28, 2024
Transcript : Raymond James Financial, Inc. Presents at UBS Financial Services Conference 2024, Feb-27-2024 01:00 PM
Transcript : Africa Oil Corp., Q4 2023 Earnings Call, Feb 27, 2024
Blueprint Medicines Highlights AYVAKIT Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
AQ
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
AQ
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
AQ
Cogent Biosciences Announces Positive Part 1B Data from Summit Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
CI
Transcript : Flow Traders Ltd., Q4 2023 Earnings Call, Feb 08, 2024
Transcript : Deciphera Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 06, 2024
Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
BU
Transcript : Cogent Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 04:30 PM
Transcript : Deciphera Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 04:30 PM
Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18
BU
2023: a Freja Retrospective
PU
Blueprint Medicines' AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only Treatment for Indolent Systemic Mastocytosis
PR
Transcript : Cogent Biosciences, Inc. - Special Call
Transcript : Inhibikase Therapeutics, Inc., Q3 2023 Earnings Call, Nov 15, 2023
Transcript : ReWalk Robotics Ltd., Q3 2023 Earnings Call, Nov 14, 2023
Blueprint Medicines' AYVAKYT® (avapritinib) Receives Positive CHMP Opinion as the First and Only Therapy for Indolent Systemic Mastocytosis
PR
Transcript : Gielda Papierów Wartosciowych w Warszawie S.A., Q3 2023 Earnings Call, Nov 10, 2023
Transcript : Shoals Technologies Group, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Transcript : Park Hotels & Resorts Inc., Q3 2023 Earnings Call, Nov 02, 2023
Transcript : Eli Lilly and Company, Q3 2023 Earnings Call, Nov 02, 2023
Transcript : Endeavour Group Limited - Shareholder/Analyst Call
Transcript : Deciphera Pharmaceuticals, Inc., Q3 2023 Earnings Call, Oct 30, 2023
Deciphera Pharmaceuticals Announces Positive Top-line Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) and Updated Results from Phase 1/2 Study of Vimseltinib in TGCT
BU
Deciphera Pharmaceuticals, Inc. Announces Positive Top-Line Results from Motion Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor
CI
Transcript : Elastic N.V. - Special Call
Transcript : Westlife Foodworld Limited, Q2 2024 Earnings Call, Oct 26, 2023
Transcript : Rush Enterprises, Inc., Q3 2023 Earnings Call, Oct 25, 2023
Transcript : Nippon Telegraph and Telephone Corporation - Analyst/Investor Day
Odd bond calm loosening Fed squeeze: Mike Dolan
RE
Transcript : Growthpoint Properties Limited, 2023 Earnings Call, Sep 14, 2023
Transcript : Cogent Biosciences, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 08:10 AM
Transcript : Tsakos Energy Navigation Limited, Q2 2023 Earnings Call, Sep 07, 2023
Transcript : Eagers Automotive Limited, H1 2023 Earnings Call, Aug 24, 2023
Transcript : Thungela Resources Limited, H1 2023 Earnings Call, Aug 21, 2023
Transcript : Stella International Holdings Limited, H1 2023 Earnings Call, Aug 17, 2023
Transcript : Nova Ljubljanska Banka d.d., H1 2023 Earnings Call, Aug 10, 2023
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results
PR
Transcript : Raia Drogasil S.A., Q2 2023 Earnings Call, Aug 09, 2023
No results for this search
  1. Stock Market
  2. Advanced search
  3. Daily Gist
  4. News